This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
See what results to expect from zero based budgeting and how to monitor progress with clear, actionable metrics.
19,375 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A sharp May rally pushed Planet Labs stock higher on renewed growth expectations and a favorable data-demand backdrop...
Plug Power has been in the spotlight for its hydrogen fuel cell ambitions and aggressive expansion. This guide breaks...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
A recent SEC Form 4 shows a Teladoc executive sold roughly $71,000 worth of stock. This article breaks down what that...
When a company posts a robust quarter, insider stock moves often draw attention. This article unpacks the sale by the...
Rivian stock rallied today as investors weighed new partnerships, production progress, and autonomous-driving milesto...
Visa’s CFO signaled that stablecoins and agentic commerce are not material to near-term growth, as the payments giant...
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
A bold AI forecast for the 2026 World Cup group stage is shaping crypto bets as traders price in the most unexpected ...
Dominion Energy 2025 earnings shaped the 2026 outlook. This analysis breaks down the Q4 results, key drivers, and wha...